NCT00617799 2023-10-10
Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma
University of Nebraska
Completed
Clinical Trials
6 trialsNCT01328535 2020-10-22
Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
Mayo Clinic
Phase 2 Completed
NCT00658892 2017-05-25
Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma
Mayo Clinic
Phase 1 Completed
NCT01388569 2017-05-17
Biomarkers in Blood Samples From Patients With Stage IV Melanoma Previously Treated With Sargramostim
Eastern Cooperative Oncology Group
Completed
NCT01082198 2013-08-26
Melanoma Vaccine in Treating Patients With Stage III Melanoma After Surgery to Remove Lymph Nodes
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT00492440 2012-10-18
Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer
Cytheris SA
Phase 1 Terminated